A computational prospective on isoform-selective CB2 inhibitors

被引:0
|
作者
Zhao, Yi [1 ]
Wang, Ying [2 ]
Wang, Huibin [1 ]
Hu, Baichun [3 ,4 ]
Luo, Zhaohu [2 ]
Zhang, Fengjiao [2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Shenyang 110016, Peoples R China
[3] Shenyang Pharmaceut Univ, Minist Educ, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China
[4] Shenyang Pharmaceut Univ, Sch Pharmaceut Engn, Shenyang 110016, Peoples R China
关键词
CB1R INVERSE AGONIST; CANNABINOID RECEPTOR; OVERWEIGHT PATIENTS; MOLECULAR-DYNAMICS; ACCURATE DOCKING; DISCOVERY; POTENT; GLIDE; ANTAGONIST; TARANABANT;
D O I
10.1039/d1nj02296b
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cannabinoid (CB) receptors play a vital role in many pathophysiological processes. Selective CB2 activation may lead to the immuno-modulatory effects of cannabinoids being experienced without the psychoactive effects of CB1 activation; however, despite intense efforts, selective and potent CB2 agonists still remain to be developed likely due to the challenges associated with their unexpected CB1 affinity. The aim of this study was therefore to illuminate the selective mechanisms of CB1 and CB2 receptors via analyzing their interaction modes with highly selective ligands. It was found that although CB1 and CB2 exhibit high sequence homology, especially at ligand binding regions, the binding pocket of CB1 is a narrow cross shaped slit that is enclosed by several hydrophobic residues, whereas the binding pocket of CB2 is large and round and therefore would allow for more flexible ligands. In fact, hydrophobic interactions mainly account for the receptor-ligand interactions of both CB1 and CB2, with the key residues that determine the receptor selectivity being MET103, PHE170, VAL196, and PHE268 for CB1, and PHE87, PHE183, PHE94, and TRP194 for CB2. Therefore, the strategy of enlarging the molecular size, increasing hydrogen bond interactions with the key residues of CB2, and furthering the geometric distribution of hydrophobic groups would improve the selectivity towards the CB2 receptor. Collectively, these data shed promising light on elucidating the selective mechanisms between CB1 and CB2, which would lay a solid foundation for the future design of selective inhibitors towards CB2.
引用
收藏
页码:12688 / 12699
页数:12
相关论文
共 50 条
  • [1] Isoform-selective histone deacetylase inhibitors
    Bieliauskas, Anton V.
    Pflum, Mary Kay H.
    CHEMICAL SOCIETY REVIEWS, 2008, 37 (07) : 1402 - 1413
  • [2] Isoform-selective histone deacetylase inhibitors
    Itoh, Yukihiro
    Suzuki, Takayoshi
    Miyata, Naoki
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (06) : 529 - 544
  • [3] Explorative Study on Isoform-Selective Histone Deacetylase Inhibitors
    Suzuki, Takayoshi
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2009, 57 (09) : 897 - 906
  • [4] Investigation and synthesis of isoform-selective histone deacetylase inhibitors
    O'Neill, Matthew
    Wiest, Olaf
    Helquist, Paul
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [5] Development of isoform-selective protein arginine methyltransferase inhibitors
    Zheng, Y. George
    Ivanov, Ivaylo
    Qian, Kun
    Yan, Chunli
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [6] Design of isoform-selective inhibitors of nitric oxide synthase
    Babu, BR
    Griffith, OW
    CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) : 491 - 500
  • [7] Isoform-selective HDAC inhibitors: Closing in on translational medicine for the heart
    McKinsey, Timothy A.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2011, 51 (04) : 491 - 496
  • [8] Modulation of the Circadian Period: Searching for Isoform-Selective Cyclophilin Inhibitors
    Yousefi, Ali
    Kringen, Kiernan
    Noland, Ryan
    McShan, Andrew
    Lokey, Scott
    Partch, Carrie L.
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 417A - 418A
  • [9] Engineering of chimeric carbonic anhydrases for designing isoform-selective inhibitors
    Smirnoviene, Joana
    Smirnov, Alexey
    Kairys, Visvaldas
    Kazokaite-Adomaitiene, Justina
    Mickeviciute, Aurelija
    Michailoviene, Vilma
    Manakova, Elena
    Baranauskiene, Lina
    Matulis, Daumantas
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2021, 50 (SUPPL 1): : 127 - 127
  • [10] PI3K Isoform-Selective Inhibitors in Cancer
    Duncan, Leslie
    Shay, Chloe
    Teng, Yong
    SINGLE-CELL SEQUENCING AND METHYLATION: METHODS AND CLINICAL APPLICATIONS, 2020, 1255 : 165 - 173